CD274 and non-small cell lung carcinoma: Recently the FDA has approved several PD-L1 antibody clones for diagnostic use in Non-Small Cell Lung Cancer (NSCLC), but their validation on different tumor types and especially the definition of threshold in terms of the percentage of positive cells is still in progress [14].